Catheter ablation of atrioventricular nodal reentrant tachycardia with an irrigated contact‐force sensing radiofrequency ablation catheter

Introduction Radiofrequency ablation (RFA) slow pathway modification for catheter ablation of atrioventricular nodal reentrant tachycardia (AVNRT) is traditionally performed using a 4‐mm nonirrigated (NI) RF ablation catheter. Slow pathway modification using irrigated, contact‐force sensing (ICFS) R...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular electrophysiology Vol. 34; no. 4; pp. 942 - 946
Main Authors Panday, Priya, Holmes, Douglas, Park, David S., Jankelson, Lior, Bernstein, Scott A., Knotts, Robert, Kushnir, Alexander, Aizer, Anthony, Chinitz, Larry A., Barbhaiya, Chirag R.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction Radiofrequency ablation (RFA) slow pathway modification for catheter ablation of atrioventricular nodal reentrant tachycardia (AVNRT) is traditionally performed using a 4‐mm nonirrigated (NI) RF ablation catheter. Slow pathway modification using irrigated, contact‐force sensing (ICFS) RFA catheters has been described in case reports, but the outcomes have not been systematically evaluated. Methods Acute procedural outcomes of 200 consecutive patients undergoing slow pathway modification for AVNRT were analyzed. A 3.5‐mm ICFS RFA catheter (ThermoCool SmartTouch STSF, Biosense Webster, Inc.) was utilized in 134 patients, and a 4‐mm NI RFA catheter (EZ Steer, Biosense Webster, Inc.) was utilized in 66 patients. Electroanatomic maps were retrospectively analyzed in a blinded fashion to determine the proximity of ablation lesions to the His region. Results The baseline characteristics of patients in both groups were similar. Total RF time was significantly lower in the ICFS group compared to the NI group (5.53 ± 4.6 vs. 6.24 ± 4.9 min, p = 0.03). Median procedure time was similar in both groups (ICFS, 108.0 (87.5–131.5) min vs. NI, 100.0 (85.0–125.0) min; p = 0.2). Ablation was required in closer proximity to the His region in the NI group compared to the ICFS group (14.4 ± 5.9 vs. 16.7 ± 6.4 mm, respectively, p = 0.01). AVNRT was rendered noninducible in all patients, and there was no arrhythmia recurrence during follow‐up in both groups. Catheter ablation was complicated by AV block in one patient in the NI group. Conclusion Slow pathway modification for catheter ablation of AVNRT using an ICFS RFA catheter is feasible, safe, and may facilitate shorter duration ablation while avoiding ablation in close proximity to the His region.
Bibliography:Disclosures
Relationships to the industry are all modest (<$10 000). Chirag R. Barbhaiya has received speaking fees/honoraria from Biosense Webster, Inc., Abbott, Inc. and Zoll, Inc. Anthony Aizer receives fellowship support from Abbott, Inc., Biotronik, Inc., Boston Scientific, Inc., and Medtronic, Inc. Larry A. Chinitz has received speaking fees/honoraria from Abbott Medical, Inc., Medtronic, Inc., Biotronik, Inc., Biosense Webster, Inc. Other authors: no disclosures.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1045-3873
1540-8167
DOI:10.1111/jce.15849